What clinical evidence supports GLP-1 use in metabolically healthy normal-weight people
Adults with type 2 diabetes (T2DM) initiating GLP-1 RAs or DPP-4is between January 1, 2018, and December 31, 2022, were identified, excluding prior users of either class
NeuroReport 12(6):12931296
Injection site reactions, transient fatigue, and mild headaches occur but typically resolve quickly
China Patent CN102586369 (B) Liang G, Du G, Chen J (2008a) A novel strategy of enhanced glutathione production in high cell density cultivation of Candida utilis Cysteine addition combined with dissolved oxygen controlling
Injectable L-Carnitine Benefits Injectable L-Carnitine is designed to bypass the digestive system entirely, allowing for more direct and efficient delivery into the bloodstream